238 related articles for article (PubMed ID: 15485863)
21. Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases.
Kanelakis KC; Palomino HL; Li L; Wu J; Yan W; Rosen MD; Rizzolio MC; Trivedi M; Morton MF; Yang Y; Venkatesan H; Rabinowitz MH; Shankley NP; Barrett TD
J Biomol Screen; 2009 Jul; 14(6):627-35. PubMed ID: 19498081
[TBL] [Abstract][Full Text] [Related]
22. Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor gene product.
Pereira T; Zheng X; Ruas JL; Tanimoto K; Poellinger L
J Biol Chem; 2003 Feb; 278(9):6816-23. PubMed ID: 12468553
[TBL] [Abstract][Full Text] [Related]
23. Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Tuckerman JR; Zhao Y; Hewitson KS; Tian YM; Pugh CW; Ratcliffe PJ; Mole DR
FEBS Lett; 2004 Oct; 576(1-2):145-50. PubMed ID: 15474027
[TBL] [Abstract][Full Text] [Related]
24. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets.
Myllyharju J
Ann Med; 2008; 40(6):402-17. PubMed ID: 19160570
[TBL] [Abstract][Full Text] [Related]
25. Effects of polynitrogen compounds on the activity of recombinant human HIF-1α prolyl hydroxylase 3 in E. coli.
Geng Z; Zhu J; Cao J; Geng J; Song X; Zhang Z; Bian N; Wang Z
J Inorg Biochem; 2011 Mar; 105(3):391-9. PubMed ID: 21421125
[TBL] [Abstract][Full Text] [Related]
26. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases.
Bruegge K; Jelkmann W; Metzen E
Curr Med Chem; 2007; 14(17):1853-62. PubMed ID: 17627521
[TBL] [Abstract][Full Text] [Related]
27. The active site of an algal prolyl 4-hydroxylase has a large structural plasticity.
Koski MK; Hieta R; Böllner C; Kivirikko KI; Myllyharju J; Wierenga RK
J Biol Chem; 2007 Dec; 282(51):37112-23. PubMed ID: 17940281
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
29. Substrate specificity of cucumisin on synthetic peptides.
Yonezawa H; Kaizuka H; Uchikoba T; Arima K; Kaneda M
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2104-8. PubMed ID: 11129582
[TBL] [Abstract][Full Text] [Related]
30. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
[TBL] [Abstract][Full Text] [Related]
31. Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity.
Lancaster DE; McNeill LA; McDonough MA; Aplin RT; Hewitson KS; Pugh CW; Ratcliffe PJ; Schofield CJ
Biochem J; 2004 Nov; 383(Pt. 3):429-37. PubMed ID: 15239670
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of a viral prolyl hydroxylase.
Langley GW; Abboud MI; Lohans CT; Schofield CJ
Bioorg Med Chem; 2019 Jun; 27(12):2405-2412. PubMed ID: 30737136
[TBL] [Abstract][Full Text] [Related]
33. Collagen prolyl 4-hydroxylase tetramers and dimers show identical decreases in Km values for peptide substrates with increasing chain length: mutation of one of the two catalytic sites in the tetramer inactivates the enzyme by more than half.
Kukkola L; Koivunen P; Pakkanen O; Page AP; Myllyharju J
J Biol Chem; 2004 Apr; 279(18):18656-61. PubMed ID: 14985345
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF.
Koivunen P; Hirsilä M; Remes AM; Hassinen IE; Kivirikko KI; Myllyharju J
J Biol Chem; 2007 Feb; 282(7):4524-4532. PubMed ID: 17182618
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.
Miller F; Kentsis A; Osman R; Pan ZQ
J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064
[TBL] [Abstract][Full Text] [Related]
36. Primary and tertiary structure of the principal human adenylate kinase.
Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
[TBL] [Abstract][Full Text] [Related]
37. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha.
Chan DA; Sutphin PD; Denko NC; Giaccia AJ
J Biol Chem; 2002 Oct; 277(42):40112-7. PubMed ID: 12186875
[TBL] [Abstract][Full Text] [Related]
38. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.
Chan DA; Sutphin PD; Yen SE; Giaccia AJ
Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780
[TBL] [Abstract][Full Text] [Related]
39. A conserved family of prolyl-4-hydroxylases that modify HIF.
Bruick RK; McKnight SL
Science; 2001 Nov; 294(5545):1337-40. PubMed ID: 11598268
[TBL] [Abstract][Full Text] [Related]
40. 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
Mole DR; Schlemminger I; McNeill LA; Hewitson KS; Pugh CW; Ratcliffe PJ; Schofield CJ
Bioorg Med Chem Lett; 2003 Aug; 13(16):2677-80. PubMed ID: 12873492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
